N-acetyl Selank is a modified form of Selank, a synthetic tuftsin-like peptide studied mainly for anxiety-like behavior, stress response, and neurotransmitter effects. Most accessible evidence is animal or mechanistic, not large human trials. It is not a standard FDA-approved anxiety medication in the U.S., and Chia does not offer Selank.
Wondering if NAD+ is right for you? Take the 3-min clinical quiz.
See if you qualify →What is N-acetyl Selank peptide?
N-acetyl Selank is a lab-made version of Selank, a synthetic heptapeptide related to tuftsin. The parent peptide, Selank, is described in the scientific literature as Thr-Lys-Pro-Arg-Pro-Gly-Pro, often shortened to TKPRPGP 1. For a broader patient guide to the parent compound, see our article on what Selank peptide is.
Tuftsin is a short natural peptide fragment linked to immune signaling. Selank keeps tuftsin’s core sequence, then adds three proline-containing amino acids. Researchers designed this change to make the peptide more stable than tuftsin in experimental systems 1.
How Selank relates to tuftsin
Selank is often called a tuftsin analog. That means it is not tuftsin itself, but it is built from the same core peptide sequence and then extended. In the animal literature, it is described as a regulatory peptide, a broad term for peptides that may affect signaling between cells 1.
What N-acetylation and amidation are meant to change
N-acetyl Selank adds an acetyl group to one end of the peptide. N-acetyl Selank amidate adds both N-terminal acetylation and C-terminal amidation. In peptide chemistry, these changes are often used to alter stability or breakdown in lab conditions, but stability claims do not prove better patient outcomes.
Why many online products are labeled for research use only
Many N-acetyl Selank and N-acetyl Selank amidate products sold online are labeled “for research use only” or “not for human or veterinary use.” FDA rules allow certain research-use-only labels for in vitro laboratory products, but that labeling does not mean a product is appropriate for people to use 7.
Quick facts about N-acetyl Selank
Selank is best understood as an investigational neuroactive peptide, not as a standard U.S. anxiety medication. The key number to remember is 1 to 3 hours: that is the timing used in one rat gene-expression study, not a reliable onset time for people 1.
- What it is: a modified form of Selank, which is a synthetic tuftsin-like heptapeptide.
- What it is studied for: anxiety-like behavior, stress response, neurotransmitter signaling, and related brain pathways.
- Human vs animal evidence: English-accessible evidence is mostly animal and mechanistic; Russian clinical literature exists but is not enough to meet the usual U.S. drug-evidence standard 5.
- What is not established: reliable dosing, onset, long-term safety, and effectiveness for anxiety in U.S. patients. Our separate guide to Selank peptide dosing explains why research doses should not be copied as a self-directed plan.
- Chia availability: Chia does not currently offer Selank, N-acetyl Selank, or N-acetyl Selank amidate.
What does Selank appear to do in the brain?
Selank appears to affect several neurotransmitter systems in animal studies, especially genes linked to GABA signaling. GABA is the brain’s main calming neurotransmitter, but changes in rat gene expression are not the same thing as proven anxiety relief in humans.
GABAergic signaling and proposed calming effects
In one rat study, researchers gave intranasal Selank or GABA at 300 μg/kg and measured 84 neurotransmission-related genes in the frontal cortex. They reported significant expression changes in 45 genes at 1 hour and 22 genes at 3 hours 1.
The authors concluded that one possible molecular mechanism involves allosteric modulation of the GABAergic system 1. “Allosteric modulation” means a compound may change how a receptor responds, rather than acting like the body’s own signal.
Gene-expression findings in rat frontal cortex
The frontal cortex helps regulate attention, planning, emotion, and stress response. The rat study found changes in genes tied to GABA receptors, transporters, ion channels, dopamine receptors, and serotonin receptors after Selank exposure 1.
Possible effects on stress, learning, and memory pathways
Other research discussions have connected Selank with stress-response pathways, monoamines such as serotonin and dopamine, enkephalins, and BDNF. These signals matter for mood and learning, but most of this work remains preclinical, meaning animal or lab-based rather than proven in large human trials 1.
Why mechanism studies do not prove clinical benefit
A mechanism can explain why a peptide is interesting. It cannot prove that it helps a person feel calmer, sleep better, or think more clearly. To prove a clinical effect, researchers need well-designed human randomized trials that measure symptoms and safety over time.
Does Selank peptide really work for anxiety?
Selank peptide has been studied for anxiety-related conditions, but the evidence is not strong enough to treat it like an established U.S. anxiety medication. The main limitation is not that the science is uninteresting; it is that the human evidence is limited and not well replicated in Western clinical trials.
What Russian clinical literature has reported
Russian clinical literature has described Selank use in generalized anxiety disorder and neurasthenia, including comparisons with benzodiazepine medications such as phenazepam. Those reports are part of the historical evidence base, but many details that U.S. clinicians expect, such as trial registration, full methods, and independent replication, are hard for patients to verify 5. Our deeper article on Selank as an anxiety and nootropic peptide explains why that evidence should be read with caution.
What the English-language animal studies show
In a rat chronic-stress study, researchers studied Selank with diazepam and reported changes in anxiety-like behavior under experimental stress conditions 2. This supports a research signal, but it does not prove that Selank works like diazepam, alprazolam, or other benzodiazepines in people.
Why the evidence is still limited for U.S. patients
For U.S. patients, the practical question is simple: has this peptide been tested in large, well-described human trials with clear safety monitoring? For Selank and N-acetyl Selank, the answer is no. That is why we frame it as investigational rather than established care.
What would be needed to establish effectiveness
A stronger evidence base would include randomized, placebo-controlled human trials in people with defined anxiety disorders, clear symptom scales, safety labs, interaction tracking, and follow-up after stopping the drug. That kind of evidence is standard for anxiety medications evaluated in the U.S. 6.
Does Selank feel like Xanax?
Selank should not be treated as a Xanax-like drug. Xanax is a brand name for alprazolam, a benzodiazepine with FDA labeling, known risks, and clear warnings; Selank is an investigational peptide in the U.S. 3.
How benzodiazepines work
Benzodiazepines, including alprazolam and diazepam, bind to benzodiazepine sites on GABA-A receptors and enhance the effect of GABA. FDA labeling for alprazolam includes boxed warnings about misuse, addiction, physical dependence, withdrawal, and serious risks when used with opioids 3.
Diazepam has similar class warnings and can cause sedation, impaired coordination, respiratory depression in high-risk settings, dependence, and withdrawal symptoms 4. These known risks are one reason anxiety medication changes should be supervised by a clinician.
How Selank has been compared mechanistically
Selank has been compared with benzodiazepine-related pathways because animal and gene-expression studies point toward GABAergic signaling 1. But “shares a pathway” does not mean “feels the same,” “works the same,” or “has the same safety profile.”
Why Selank should not replace prescribed anxiety medication
Stopping or replacing prescribed anxiety medication can cause rebound symptoms, withdrawal, panic, sleep disruption, or other harms. NIMH advises that anxiety disorders are medical conditions that can be evaluated and managed with evidence-based care, including psychotherapy and medications when appropriate 6.
When to talk to a licensed mental health or medical professional
Talk with a licensed professional if anxiety affects sleep, work, school, relationships, substance use, or safety. Seek urgent help if anxiety comes with chest pain, thoughts of self-harm, confusion, severe agitation, or symptoms that feel out of control.
How long does Selank take to work?
Selank timing is not established for patients. The clearest number in the English animal literature is 1 to 3 hours for rat frontal-cortex gene-expression changes, which should not be converted into a human onset claim 1.
What animal gene-expression timing suggests
In the rat study, gene expression was measured at 1 hour and 3 hours after intranasal Selank or GABA administration 1. That tells us researchers saw molecular changes during that lab window. It does not tell us when a person would feel an effect.
Why patient timing claims are not reliable clinical evidence
Online reports often describe fast calming effects. Those reports are not the same as controlled clinical evidence, because they can be shaped by expectation, product quality, other medications, caffeine, sleep, withdrawal, and the natural rise and fall of anxiety symptoms.
Why no dosing or timing plan should be self-directed
We do not recommend self-directed dosing with research-use-only peptides. For a peptide without U.S. FDA approval, a clear product label, or strong human safety data, there is no reliable public dosing plan that can be applied safely to an individual reader.
N-acetyl Selank vs Selank: what is the difference?
N-acetyl Selank amidate is a chemically modified form of Selank. The important difference for patients is not the lab chemistry alone, but the evidence gap: stronger stability claims do not equal proven anxiety outcomes.
Standard Selank sequence
Standard Selank is described as the heptapeptide Thr-Lys-Pro-Arg-Pro-Gly-Pro 1. It is the parent compound behind many online Selank nasal-spray and research-peptide claims.
N-acetyl Selank and N-acetyl Selank amidate modifications
N-acetyl Selank adds N-terminal acetylation. N-acetyl Selank amidate adds N-terminal acetylation plus C-terminal amidation. These are common peptide-chemistry strategies used to change how a molecule behaves in lab conditions, but patient-level safety and effectiveness still need human testing.
Stability claims vs proven patient outcomes
A peptide can be more stable in a vial, in a lab assay, or in theory, and still fail to show useful clinical effects in people. For anxiety, the outcomes that matter are symptom relief, daily function, side effects, interactions, and durability after stopping.
| Option | What it is | Evidence level | Regulatory status in the U.S. | Key safety point |
|---|---|---|---|---|
| Selank | Synthetic tuftsin-like heptapeptide, sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro | Animal, mechanistic, and limited Russian clinical literature | Not FDA-approved for anxiety | Long-term safety and drug interactions are not well established |
| N-acetyl Selank | Modified Selank with N-terminal acetylation | Mostly research and chemistry-based claims; limited human outcome data | Not FDA-approved for anxiety | Research-use-only products are not intended for human or veterinary use |
| N-acetyl Selank amidate | Modified Selank with N-terminal acetylation and C-terminal amidation | Stability claims exist, but patient outcomes are not established | Not FDA-approved for anxiety | Quality, sterility, purity, and legality can be unclear online |
| Benzodiazepines such as alprazolam or diazepam | FDA-labeled prescription medicines that act at GABA-A receptor benzodiazepine sites | Human clinical evidence and FDA labeling | FDA-approved for specific labeled uses | Known risks include sedation, dependence, withdrawal, misuse, and dangerous interactions |
Can you get N-acetyl Selank through Chia?
Chia does not currently offer Selank or N-acetyl Selank. Our live treatment catalog includes clinician-reviewed access to certain compounded GLP-1 medications and longevity treatments, but Selank is not one of them.
Chia does not currently offer Selank or N-acetyl Selank
We want to be direct: Chia does not currently prescribe Selank, N-acetyl Selank, or N-acetyl Selank amidate. If a peptide is not in our current catalog, we do not imply that we can provide it.
How Chia evaluates peptide treatments it does offer
For peptide and longevity treatments we do offer, our process starts with an online health questionnaire and licensed-provider review. Examples in our current catalog include NAD+, sermorelin, and GHK-Cu, each offered only in the forms listed on its product page. If you are comparing other neuroactive peptides, our Semax peptide dosage chart shows the same evidence-first approach we use when discussing research compounds.
When clinically appropriate, Chia prescriptions are filled by state-licensed U.S. 503A compounding pharmacies and shipped to the patient’s door. A prescription is never guaranteed, and dosing is provider-guided over time.
Why prescription and safety review matter for peptides
The main safety divide is licensed care versus no-prescription research products. FDA has warned that compounded drugs can carry risks if they are made or used outside proper quality systems, which is why pharmacy licensing, provider review, and patient follow-up matter 8.
DoctorMCP and the role of licensed-provider access when a treatment is available
When a treatment is available in Chia’s catalog, patients and supported AI-agent workflows can use DoctorMCP at mcp.chia.health to help start a licensed-provider access path. That access channel does not change the medical rule: a provider must evaluate the patient, and a prescription is not guaranteed.
What safety issues should patients understand?
N-acetyl Selank safety is not well established in long-term human use. The biggest concerns are limited human data, possible psychiatric-medication interactions, product quality, and the risk of delaying proper anxiety care.
Limited long-term human safety data
The English-accessible research base does not provide the kind of long-term safety data clinicians expect for a medicine used in anxiety disorders. That means risks may be undercounted, especially in people with panic disorder, bipolar disorder, substance-use risk, pregnancy, or complex medication lists.
Possible interactions with psychiatric medications are not well studied
Because Selank research involves GABA, serotonin, dopamine, and stress-related pathways, interactions with psychiatric medications cannot be ruled out. This is especially important for people taking benzodiazepines, SSRIs, SNRIs, stimulants, sleep medications, opioids, or alcohol.
Quality and legality concerns with research-use-only peptides
Research-use-only peptides may not be tested, labeled, stored, or dispensed like prescription medicines. A vial or nasal spray bought online may have uncertain identity, potency, sterility, contaminants, or instructions, and research-use-only labeling means it is not intended for human or veterinary use 7. We cover related risks in our guide to peptide group buys, including why no-prescription sourcing can create safety and legality problems.
Why anxiety symptoms deserve proper evaluation
Anxiety can come from many causes, including thyroid disease, heart rhythm problems, substance use, medication side effects, trauma, depression, panic disorder, or sleep loss. NIMH notes that anxiety disorders can be evaluated and treated with evidence-based options, and early care can reduce suffering 6.
N-acetyl Selank is a modified form of Selank, a synthetic tuftsin-like peptide studied mainly for neurotransmitter signaling, stress response, and anxiety-like behavior. Most accessible evidence is animal or mechanistic, so patient benefits are not established.
No. N-acetyl Selank is not FDA-approved for anxiety or any other indication in the U.S. It should not be treated as an approved anxiety medication.
No. Xanax is alprazolam, an FDA-labeled benzodiazepine with known benefits, risks, and warnings. Selank is an investigational peptide in the U.S. and should not be used as a substitute for prescribed anxiety medication.
Selank has been studied for anxiety-related effects, and some animal and Russian clinical literature reports a signal. But the evidence is still limited for U.S. patients because large, well-described, independently replicated human trials are lacking.
A rat study measured gene-expression changes at 1 and 3 hours, but that does not prove a human onset time. Online timing claims should not be used as a dosing or treatment guide.
Long-term human safety is not well established. Possible concerns include psychiatric-medication interactions, uncertain product quality, and use of research-only products that are not intended for people.
No. Chia does not currently offer or prescribe Selank, N-acetyl Selank, or N-acetyl Selank amidate. Chia only offers treatments listed in its current live catalog after licensed-provider review.
References
- 1.Kolobov AA, Svidinenko AI, Bobyntsev II, et al. Effects of Selank and GABA on the expression of genes involved in neurotransmission in the rat frontal cortex. Molecular Biology Reports. 2016.
- 2.Vakhitova YV, Sadovnikov SV, Borisevich SS, et al. Effects of Selank and diazepam on anxiety-like behavior and neurotransmitter-related systems in rats under chronic stress. Bulletin of Experimental Biology and Medicine. 2017.
- 3.U.S. Food and Drug Administration. Xanax (alprazolam) prescribing information. 2023.
- 4.U.S. Food and Drug Administration. Valium (diazepam) prescribing information. 2021.
- 5.Seredenin SB, Kozlovskaia MM, Blednov YA, et al. Selank in the treatment of generalized anxiety disorder and neurasthenia. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2008.
- 6.National Institute of Mental Health. Anxiety Disorders. 2024.
- 7.U.S. Food and Drug Administration. Distribution of In Vitro Diagnostic Products Labeled for Research Use Only or Investigational Use Only: Guidance for Industry and FDA Staff. 2013.
- 8.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2024.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if NAD+ is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
